Literature DB >> 12727645

Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus.

George C Tsokos1, Madhusoodana P Nambiar, Yuang-Taung Juang.   

Abstract

Elf-1, a member of the Ets transcription factor family with an estimated molecular mass of 68 kDa, is involved in the transcriptional regulation of several hematopoietic cell genes. It is shown that following O-GlcNAc glycosylation and phosphorylation by PKC theta, the cytoplasm-located, 80-kDa Elf-1 translocates to the nucleus as a 98-kDa protein. In the nucleus, Elf-1 binds to the promoter of the TCR zeta gene and promotes its transcription in Jurkat and fresh human T cells. It is also shown that in the majority of patients with systemic lupus erythematosus (SLE), who are known to express decreased levels of T cell receptor (TCR) zeta chain and mRNA, the 80-kDa Elf-1 protein does not undergo proper post-transcriptional modification, which results in low levels of the 98-kDa protein, lack of Elf-binding to the TCR zeta promoter, and decreased gene transcription. Therefore, a novel activation pathway for a member of the Ets family of transcription factors, which is defective in patients with systemic autoimmunity, has been revealed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727645     DOI: 10.1111/j.1749-6632.2003.tb06054.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 2.  O-GlcNAc: a novel regulator of immunometabolism.

Authors:  Miranda Machacek; Chad Slawson; Patrick E Fields
Journal:  J Bioenerg Biomembr       Date:  2018-02-06       Impact factor: 2.945

Review 3.  Modulation of transcription factor function by O-GlcNAc modification.

Authors:  Sabire Ozcan; Sreenath S Andrali; Jamie E L Cantrell
Journal:  Biochim Biophys Acta       Date:  2010-03-02

4.  Overexpression of X-linked genes in T cells from women with lupus.

Authors:  Anura Hewagama; Gabriela Gorelik; Dipak Patel; Punsisi Liyanarachchi; W Joseph McCune; Emily Somers; Tania Gonzalez-Rivera; Faith Strickland; Bruce Richardson
Journal:  J Autoimmun       Date:  2013-02-19       Impact factor: 7.094

Review 5.  O-Linked β-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy.

Authors:  Zafer Gurel; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2018-01-19       Impact factor: 6.124

6.  Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.

Authors:  Michael Boyce; Isaac S Carrico; Anjali S Ganguli; Seok-Ho Yu; Matthew J Hangauer; Sarah C Hubbard; Jennifer J Kohler; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

Review 7.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

Review 8.  O-GlcNAc cycling: implications for neurodegenerative disorders.

Authors:  Brooke D Lazarus; Dona C Love; John A Hanover
Journal:  Int J Biochem Cell Biol       Date:  2009-03-27       Impact factor: 5.085

9.  The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells.

Authors:  J L Svenson; K Chike-Harris; M Y Amria; T K Nowling
Journal:  Genes Immun       Date:  2009-10-15       Impact factor: 2.676

Review 10.  Metabolic control of the epigenome in systemic Lupus erythematosus.

Authors:  Zachary Oaks; Andras Perl
Journal:  Autoimmunity       Date:  2013-10-16       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.